7-150947795-GC-GCC

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The ENST00000262186.10(KCNH2):​c.2775_2776insG​(p.Pro926AlafsTer14) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000196 in 1,532,044 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β˜…β˜…). Synonymous variant affecting the same amino acid position (i.e. G925?) has been classified as Pathogenic. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

KCNH2
ENST00000262186.10 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: -1.37
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-150947795-G-GC is Pathogenic according to our data. Variant chr7-150947795-G-GC is described in ClinVar as [Pathogenic]. Clinvar id is 200672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNH2NM_000238.4 linkuse as main transcriptc.2775_2776insG p.Pro926AlafsTer14 frameshift_variant 12/15 ENST00000262186.10 NP_000229.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNH2ENST00000262186.10 linkuse as main transcriptc.2775_2776insG p.Pro926AlafsTer14 frameshift_variant 12/151 NM_000238.4 ENSP00000262186 P1Q12809-1
KCNH2ENST00000330883.9 linkuse as main transcriptc.1755_1756insG p.Pro586AlafsTer14 frameshift_variant 8/111 ENSP00000328531 Q12809-2
KCNH2ENST00000684241.1 linkuse as main transcriptn.3608_3609insG non_coding_transcript_exon_variant 10/13

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151982
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000783
AC:
1
AN:
127658
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
69796
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000213
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.25e-7
AC:
1
AN:
1380062
Hom.:
0
Cov.:
36
AF XY:
0.00000147
AC XY:
1
AN XY:
680378
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000274
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151982
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74230
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000869
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxJun 15, 2022Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22988594, 21215473, 21419236, 24065925, 23304551, 28363160, 10973849, 20181576, 22956155, 30369311, 26669661, 29739726, 16922724, 32383558, 34319147, 34127479, 27000522) -
Pathogenic, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 05, 2023The KCNH2 c.2775dup; p.Pro926Alafs*14 variant (rs794728455) is reported in the literature in multiple individuals in the heterozygous state affected with Long QT syndrome (Choi 2021, Nof 2010, Westphal 2020, Zarraga 2011). This variant is reported in ClinVar (Variation ID: 200672) and is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. In vitro/In vivo functional analyses demonstrate reduced cellular currents (Nof 2010, Zarraga 2011). This variant causes a frameshift by inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Choi SH et al. Rare Coding Variants Associated with Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis. Circ Genom Precis Med. 2021. PMID: 34319147. Nof E et al. A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death. Circ Cardiovasc Genet. 2010. PMID: 20181576. Westphal DS. Reclassification of genetic variants in children with long QT syndrome. Mol Genet Genomic Med. 2020. PMID: 32383558. Zarraga IG et al. Nonsense-mediated mRNA decay caused by a frameshift mutation in a large kindred of type 2 long QT syndrome. Heart Rhythm. 2011. PMID: 21419236. -
Long QT syndrome Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 04, 2024This sequence change creates a premature translational stop signal (p.Pro926Alafs*14) in the KCNH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNH2 are known to be pathogenic (PMID: 10973849, 19862833). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with long QT syndrome (PMID: 10973849, 20181576, 21419236). ClinVar contains an entry for this variant (Variation ID: 200672). For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthSep 18, 2023This variant causes a duplication of 1 nucleotide in exon 12 of the KCNH2 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. Functional studies have shown that this variant causes decreased expression of KCNH2 resulting in a reduction in channel current density in HEK293 cells (PMID: 20181576, 21419236). This variant has been reported in at least eight unrelated individuals affected with long QT syndrome (PMID: 10973849, 21419236, 20181576, 26669661, 30369311, 32383558). It has been shown that this variant segregates with disease in multiple individuals from two of these families (PMID: 20181576, 21419236). This variant has also been reported in an individual affected with sudden cardiac death (PMID: 27000522). This variant has been identified in 1/127658 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of KCNH2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
Long QT syndrome 2 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMSep 01, 2006- -
Long QT syndrome 1/2, digenic Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMSep 01, 2006- -
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsOct 28, 2021The c.2775dupG pathogenic mutation, located in coding exon 12 of the KCNH2 gene, results from a duplication of G at nucleotide position 2775, causing a translational frameshift with a predicted alternate stop codon (p.P926Afs*14). This alteration was identified in several members of a large long QT syndrome type 2 (LQTS2) kindred with complete segregation in affected individuals (Zarraga IG et al. Heart Rhythm. 2011;8(8):1200-6). Functional analysis from this group demonstrated this duplication results in the absence of protein from this allele. This alteration was also reported in affected relatives in a family with a history of sudden cardiac death and prolonged QTc intervals (Cann F et al, 2017 01;91:22-29). Additionally, this alteration was reported as heterozygous in a child and mother both affected with LQTS2. The mother had a history of two other pregnancies with this alteration in addition to a paternally inherited KCNH2 alteration; these babies did not survive, and functional studies indicated that the effect of both alterations together is more severe than either alone (Nof E et al. Circ Cardiovasc Genet. 2010;3(2):199-206). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Cardiac arrhythmia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJul 24, 2023This variant causes a duplication of 1 nucleotide in exon 12 of the KCNH2 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. Functional studies have shown that this variant causes decreased expression of KCNH2 resulting in a reduction in channel current density in HEK293 cells (PMID: 20181576, 21419236). This variant has been reported in at least eight unrelated individuals affected with long QT syndrome (PMID: 10973849, 21419236, 20181576, 26669661, 30369311, 32383558). It has been shown that this variant segregates with disease in multiple individuals from two of these families (PMID: 20181576, 21419236). This variant has also been reported in an individual affected with sudden cardiac death (PMID: 27000522). This variant has been identified in 1/127658 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of KCNH2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs794728455; hg19: chr7-150644883; API